Adaptive Properties of Monoaminergic Neurons

  • Michael J. Zigmond
  • Edward M. Stricker

Abstract

Neural systems often serve to transmit information rapidly from one region to another. As such, they are highly responsive to alterations in input, quickly translating these signals into isomorphic changes in distal targets. This is the way in which primary sensory afferent and skeletal motor efferent pathways operate. The prototypical synapse for such systems is the mammalian neuromuscular junction. Here, acetylcholine produces a rapid but transient alteration of membrane conductance, thereby generating a postsynaptic potential of millisecond duration. Transmission at these synapses can operate over a wide range of frequencies and for extended periods of time.

Keywords

Tyrosine Hydroxylase Transmitter Release Monoaminergic System Adaptive Property Tyrosine Hydroxylase Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kebabian, J. W., Petzold, G. L., and Greengard, P., 1972, Prod. Natl. Acad. Sci. U.S.A. 69: 2145–2149.CrossRefGoogle Scholar
  2. 2.
    Stoof, J. C., and Kebabian, J. W., 1981, Nature 294: 366–369.PubMedCrossRefGoogle Scholar
  3. 3.
    Strecker, R. E., Steinfels, G. F., and Jacobs, B. L., 1983, Brain Res. 260: 317–321.PubMedCrossRefGoogle Scholar
  4. 4.
    Thierry, A. M., Tassin, J. P., Blanc, G., and Glowinski, J., 1976, Nature 263: 242–244.PubMedCrossRefGoogle Scholar
  5. 5.
    Tissari, A. H., Argiolas, A., Fadda, F., Serra, G., and Gessa, G. L., 1979, Naunyn Schmiedebergs Arch. Pharmacol. 308: 155–157.PubMedCrossRefGoogle Scholar
  6. 6.
    Chiodo, L. A., Antelman, S. M., Caggiula, A. R., and Lineberry, C. G., 1980, Brain Res. 189: 544–549.PubMedCrossRefGoogle Scholar
  7. 7.
    Hommer, D. W., and Bunney, B. S., 1980, Life Sci. 27: 377–386.PubMedCrossRefGoogle Scholar
  8. 8.
    Steinfels, G. F., Heym, J., Strecker, R. E., and Jacobs, B. L., 1983, Brain Res. 258: 217–228.PubMedCrossRefGoogle Scholar
  9. 9.
    Keller, R. W., Jr., Stricker, E. M., and Zigmond, M. J., 1983, Brain Res. 279: 159–170.PubMedCrossRefGoogle Scholar
  10. 10.
    Bhatnagar, B. K., and Moore, K. E., 1971, J. Pharm. Pharmacol. 23: 625–627.PubMedCrossRefGoogle Scholar
  11. 11.
    Murrin, L. C., and Roth, R. H., 1976, Mol. Pharrnacol. 12: 463–475.Google Scholar
  12. 12.
    Bernard, C., 1974, Lectures on the Phenomena of Life Common to Animals and Plants (originally published in 1878), Charles C Thomas, Springfield, Illinois, pp. 46–91.Google Scholar
  13. 13.
    Wang, R. Y., and Aghajanian, G. K., 1977, Brain Res. 132: 186–193.PubMedCrossRefGoogle Scholar
  14. 14.
    Aghajanian, G. K., Cedarbaum, J. M., and Wang, R. Y. 1977, Brain Res. 136: 570–577.PubMedCrossRefGoogle Scholar
  15. 15.
    Groves, P. M., Wilson, C. J., Young, S. J., and Rebec, G. V., 1975, Science 190: 522–529.PubMedCrossRefGoogle Scholar
  16. 16.
    Langer, S. Z., 1979, The Release of Catecholamines from Adrenergic Neurons (D. M. Paton, ed.), Pergamon Press, Oxford, pp. 59–85.Google Scholar
  17. 17.
    Kilbinger, H., and Wessler, I., 1980, Neuroscience 5: 1331–1340.PubMedCrossRefGoogle Scholar
  18. 18.
    Starke, K., 1979, The Release of Catecholamines from Adrenergic Neurons (D. M. Paton, ed.), Pergamon Press, Oxford, pp. 143–183.Google Scholar
  19. 19.
    Szerb, J. C., 1979, Presynaptic Receptors (S. Z. Langer, K. Starke, and M. L. Dubocovich, eds.), Pergamon Press, Oxford, pp. 293–298.Google Scholar
  20. 20.
    Chang, C. C., and Chiueh, C. C., 1968, J. Pharm. Pharmacol. 20: 157–159.PubMedCrossRefGoogle Scholar
  21. 21.
    Gillis, C. N., 1963, Biochem. Pharmacol. 12: 593–596.PubMedCrossRefGoogle Scholar
  22. 22.
    Lee, C.-M., Javitch, J. A., and Snyder, S. H., 1983, Science 220: 626–629.PubMedCrossRefGoogle Scholar
  23. 23.
    Thierry, A. M., Javoy, F., Glowinski, J., and Kety, S. S., 1968, J. Pharmacol. Exp. Ther. 163: 163–171.PubMedGoogle Scholar
  24. 24.
    Welch, B. L., Hendley, E. D., and Turek, I., 1974, Science 183: 220–221.PubMedCrossRefGoogle Scholar
  25. 25.
    Hedqvist, P., 1981, Chemical Neurotransmission 75 Years (L. Stjarne, P. Hedqvist, H. Lagercrantz, and A. Wennmalm, eds.), Academic Press, London, pp. 223–233.Google Scholar
  26. 26.
    Stjarne, L., 1979, The Release of Catecholamines from Adrenergic Neurons (D. M. Paton, ed.), Pergamon Press, Oxford, pp. 111–142.Google Scholar
  27. 27.
    Taube, H. D., Starke, K., and Borowski, E., 1977, Naunyn Schmiedebergs Arch. Pharmacol. 299: 123–141.PubMedCrossRefGoogle Scholar
  28. 28.
    Giorguieff, M. F., Le Floc’h, M. L., Glowinski, J., and Besson, M. J., 1977, J. Pharmacol. Exp. Ther. 200: 535–544.PubMedGoogle Scholar
  29. 29.
    Lehmann, J., and Langer, S. Z., 1982, Brain Res. 248: 61–69.PubMedCrossRefGoogle Scholar
  30. 30.
    De Belleroche, J., and Bradford, H. F., 1978, Brain Res. 142: 53–68.PubMedCrossRefGoogle Scholar
  31. 31.
    Westfall, T. C., 1974, Neuropharmacology 13: 693–700.PubMedCrossRefGoogle Scholar
  32. 32.
    Hertting, G., Zumstein, A., Jackisch, R., Hoffmann, I., and Starke, K., 1980 Naunyn Schmiedebergs Arch. Pharmacol. 315: 111–117.PubMedCrossRefGoogle Scholar
  33. 33.
    Kapatos, G., and Zigmond, M. J., 1979, J. Pharmacol. Exp. Ther. 208: 468–475.PubMedGoogle Scholar
  34. 34.
    Bunney, B. S., 1979, The Neurobiology of Dopamine (A. S. Horn, J. Korf, and B. H. C. Westerink, eds.), Academic Press, London, pp. 417–452.Google Scholar
  35. 35.
    Szerb, J. C., 1972, Prog. Brain Res. 36: 159–165.PubMedCrossRefGoogle Scholar
  36. 36.
    Katz, B., and Thesleff, S., 1957, Br. J. Pharmacol. Chemother. 12: 260–264.PubMedCrossRefGoogle Scholar
  37. 37.
    Kebabian, J. W., Zatz, M., Romero, J. A., and Axelrod, J., 1975, Proc. Natl. Acad. Sci. U.S.A. 72: 3735–3739.PubMedCrossRefGoogle Scholar
  38. 38.
    Muhkerjee, C., Caron, M. G., and Lefkowitz, R. J., 1975, Proc. Natl. Acad. Sci. U.S.A. 72: 1945–1949.CrossRefGoogle Scholar
  39. 39.
    Su, Y. F., Cubeddu, L., and Perkins, J. P., 1976, J. Cyclic Nucleotide Res. 2: 257–270.PubMedGoogle Scholar
  40. 40.
    Wagner, H. R., and Davis, J. N., 1979, Proc. Natl. Acad. Sci. U.S.A. 76: 2057–2061.PubMedCrossRefGoogle Scholar
  41. 41.
    Kalisker, A., Rutledge, C. O., and Perkins, J. P., 1973, Mol. Pharmacol. 9: 619–629.Google Scholar
  42. 42.
    McCall, R. B., and Aghajanian, G. K., 1979, Neuroscience 4: 1501–1510.PubMedCrossRefGoogle Scholar
  43. 43.
    Mishra, R. K., Gardner, E. L., Katzman, R., and Makman, M. H., 1974, Proc. Natl. Acad. Sci. U.S.A. 71: 3883–3887.PubMedCrossRefGoogle Scholar
  44. 44.
    Trendelenburg, U., 1966, Pharmacol. Rev. 18: 629–640.PubMedGoogle Scholar
  45. 45.
    Weiss, B., 1969, J. Pharmacol. Exp. Ther. 168: 146–152.PubMedGoogle Scholar
  46. 46.
    Strada, S. J., and Martin, M. W., 1979, Neuropharmacology of Cyclic Nucleotides: Role of Cyclic AMP in Affective Disorders, Epilepsy and Modified Behavioral States (G. C. Palmer, ed.), Urban and Schwarzenberg, Baltimore, Munich, pp. 173–196.Google Scholar
  47. 47.
    Su, Y.-F., Harden, T. K., and Perkins, J. P., 1979, J. Biol. Chem. 254: 38–41.PubMedGoogle Scholar
  48. 48.
    Zatz, M., and O’Dea, R. F., 1976, J. Cyclic Nucleotide Res. 2: 427–439.PubMedGoogle Scholar
  49. 49.
    Kopin, I. J., Breese, G. R., Krauss, K. R., and Weise, V. K., 1968, J. Pharmacol. Exp. Ther. 161: 271–278.PubMedGoogle Scholar
  50. 50.
    Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., and Atack, C. V., 1972, Naunyn Schmiedebergs Arch. Pharmacol. 275: 153–168.PubMedCrossRefGoogle Scholar
  51. 51.
    Cheney, D. L., Moroni, F., Malthe-Sorenssen, D., and Costa, E., 1978, Cholinergie Mechanisms and Psychopharmacology (Donald J. Jenden, ed.), Plenum Press, New York, pp. 551563.Google Scholar
  52. 52.
    Birks, R., and MacIntosh, F. C., 1961, Can. J. Biochem. Physiol. 39: 787–827.CrossRefGoogle Scholar
  53. 53.
    Shields, P. J., and Eccleston, D., 1972, J. Neurochem. 19: 265.PubMedCrossRefGoogle Scholar
  54. 54.
    Weiner, N., and Rabadjija, M., 1968, J. Pharmacol. Exp. Ther. 160: 61–71.PubMedGoogle Scholar
  55. 55.
    Nagatsu, T., Levitt, M., and Udenfriend, S., 1964, J. Biol. Chem. 239: 2910–2917.PubMedGoogle Scholar
  56. 56.
    Boadle-Biber, M. C., Johannessen, J. N., Narasimhachari, N., and Phan, T.-H., 1983, Biochem. Pharmacol. 32: 185–188.PubMedCrossRefGoogle Scholar
  57. 57.
    Morgenroth, V. H. III, Boadle-Biber, M. and Roth, R. H., 1974, Proc. Natl. Acad. Sci. U.S.A. 71: 4283–4287.PubMedCrossRefGoogle Scholar
  58. 58.
    Weiner, N., Lee, F.-L., Dreyer, E., and Barnes, E., 1978, Life Sci. 22: 1197–1216.PubMedCrossRefGoogle Scholar
  59. 59.
    Zivkovic, B., Guidotti, A., and Costa, E., 1974, Mol. Pharmacol. 10: 727–735.Google Scholar
  60. 60.
    Hamon, M., Bourgoin, S. Hery, F., and Simonnet, G., 1978, Mol. Pharmacol. 14: 99–110.PubMedGoogle Scholar
  61. 61.
    Kuhn, D. M., Vogel, R. L., and Lovenberg. W., 1978, Biochem. Biophys. Res. Commun. 82: 759–766.PubMedCrossRefGoogle Scholar
  62. 62.
    Morgenroth, V. H. III, Hegstrand, L. R. Roth, R. H., and Greengard, P., 1975, J. Biol. Chem. 250: 1946–1948.PubMedGoogle Scholar
  63. 63.
    Simon, J. R., Atweh, S., and Kuhar, M. J., 1976, J. Neurochem. 21, 909–922.CrossRefGoogle Scholar
  64. 64.
    Guyenet, P., Lefresne, P. Rossier, J., Beaujouan, J. C., and Glowinski, J., 1973, Brain Res. 62: 523–529.PubMedCrossRefGoogle Scholar
  65. 65.
    Chuang, D., and Costa, E., 1974, Proc. Natl. Acad. Sci. U.S.A. 71: 4570–4574.PubMedCrossRefGoogle Scholar
  66. 66.
    Mueller, R. A., Thoenen, H., and Axelrod, J., 1969, Science 163: 468–469.PubMedCrossRefGoogle Scholar
  67. 67.
    Zigmond, R. E. and Ben-Ari, Y., 1977, Proc. Natl. Acad. Sci. U.S.A. 74: 3078–3080.PubMedCrossRefGoogle Scholar
  68. 68.
    Zigmond, R. E., Chalazonitis, A., and Joh, T., 1980, Neurosci. Lett. 20: 61–65.PubMedCrossRefGoogle Scholar
  69. 69.
    Thoenen, H., Mueller, R. A. and Axelrod, J. 1970, Proc. Natl. Acari. Sci. U.S.A. 65: 58–62.CrossRefGoogle Scholar
  70. 70.
    Acheson, A. L., Kapatos, G. and Zigmond. M. J., 1981, Life Sci. 28: 1407–1420.PubMedCrossRefGoogle Scholar
  71. 71.
    Fluharty, S. J., Snyder, G. L., Stricker, E. M., and Zigmond, M. J., 1982, Soc. Nearosci., Abstr. 8: 190.Google Scholar
  72. 72.
    Hoeldtke, R., Lloyd, T. and Kaufman, S., 1974. Biochem. Biophvs. Res. Commun. 57:1045(053.Google Scholar
  73. 73.
    Reis, D. J. Joh, T. H., Ross, R. A., and Pickel, V. M., 1974, Brain Res. 81: 380–386.PubMedCrossRefGoogle Scholar
  74. 74.
    Zigmond, R. E., 1979, J. Neurochem. 32: 23–29.PubMedCrossRefGoogle Scholar
  75. 75.
    Acheson, A. L., Zigmond, M. J. and Stricker, E. M., 1980. Science 207: 537–540.PubMedCrossRefGoogle Scholar
  76. 76.
    Chiodo, L. A., Acheson. A. L. Zigmond. M. J., and Stricker, E. M. 1983. Brain Res. 264: 123–126.PubMedCrossRefGoogle Scholar
  77. 77.
    Agid, Y., Javoy, F., and Glowinski, J., 1973, Nature (New Biol.) 245: 150–151.CrossRefGoogle Scholar
  78. 78.
    Hefti. F., Melamed, E. Maher. T., and Wurtman, R. J. 1980. Soc. Neurosci, Abstr. 6: 141.Google Scholar
  79. 79.
    Zigmond, M. J., Acheson. A. L., Stachowiak, M. K. and Stricker, E. M. Arch. Neurol. 41: 856–861.Google Scholar
  80. 80.
    Burgess, S. K., Eiden, L. E., and Tessel, R. E., 1980, Soc. Nearosci. Abstr. 6: 44.Google Scholar
  81. 81.
    Bjorklund, A., and Wiklund. L. 1980. Brain Res. 191: 109–127.CrossRefGoogle Scholar
  82. 82.
    Stachowiak. M. K., Jacoby, J. H. Zigmond, M. J., and Stricker. E. M. 1983, Soc. Nearosci. Abstr. 9: 1222.Google Scholar
  83. 83.
    Victor, S. J., Baumgarten. H. G., and Lovenberg. W. 1974, J. Neurochem. 22: 541–546.Google Scholar
  84. 84.
    Pedata, F., Conte, G. L., Sorbi, S. Marconcini-Pepeu, I., and Pepeu, G., 1982, Brain Res. 233: 359–367.Google Scholar
  85. 85.
    Kuhar, M. J., Aghajanian, G. K., and Roth. R. H. 1972, Brain Res. 44: 165–176.PubMedCrossRefGoogle Scholar
  86. 86.
    Zigmond, M. J., Chalmers. J. P., Simpson, J. R., and Wurtman, R. J., 1971. J. Pharmacol. Exp. Ther. 179: 20–28.PubMedGoogle Scholar
  87. 87.
    Zigmond, R. E., Baldwin, C., and Bowers, C. W. 1971, Proc. Natl. Acad. Sci. U.S.A. 78: 3959–3963.CrossRefGoogle Scholar
  88. 88.
    Keller, H. H., Bartholini, G., and Pletscher, A., 1973, Brain Res. 64: 371–378.PubMedCrossRefGoogle Scholar
  89. 89.
    Coyle, J. T., and Campochiaro, P. 1976, J. Neurochem. 27: 673–678.PubMedCrossRefGoogle Scholar
  90. 90.
    Porcher, W., and Heller, A., 1972, J. Neurochem. 19: 1917–1930.PubMedCrossRefGoogle Scholar
  91. 91.
    Bourgoin, S., Faivre-Bauman, A., Benda, P., Glowinski. J., and Hamon, M. 1974, J. Neurochem. 23: 319–327.PubMedCrossRefGoogle Scholar
  92. 92.
    Tyce, G. M. Flock. E. V. and Owen. C. A., Jr., 1964, The Developing Brain (W. A. Himwich and H. E. Himwich, eds.). Elsevier, Amsterdam, pp. 198–203.Google Scholar
  93. 93.
    Coyle. J. T., and Axelrod, J., 1971. J. Neurochem. 18: 2061–2075.Google Scholar
  94. 94.
    Creese, 1. Burt, D. R., and Snyder, S. H., 1977, Science 197: 596–598.Google Scholar
  95. 95.
    Feltz, P., and De Champlain, J., 1972, Brain Res. 43: 601–605.PubMedCrossRefGoogle Scholar
  96. 96.
    Ungerstedt. U., 1971, Acta Physiol. Scand. [Suppl.] 367: 95–122.Google Scholar
  97. 97.
    Fleming, W. W., McPhillips. J. J., and Westfall, D. P., 1973, Rev. Physiol. Biochem. Exp. Pharmacol. 68: 55–119.Google Scholar
  98. 98.
    Minneman, K. P., 1981. Neurotransmitter Receptors, Part 2, Biogenic Amines (H. I. Yamamura and S. J. Enna, eds.), Chapman and Hall, London, New York, pp. 185–268.Google Scholar
  99. Nelson, D. L. Herbet, A. Bourgoin, S., Glowinski. J., and Hamon, M., 1978. offol. Pharmacol. 14:983–995.Google Scholar
  100. 100.
    Nagy, J. I., Lee, T., Seeman, P., and Fibiger, H. C., 1978, Nature 274: 278–281.PubMedCrossRefGoogle Scholar
  101. 101.
    Sporn, J. R., Harden, T. K., Wolfe, B. B. and Molinoff. P. B., 1976. Science 194: 624–626.PubMedCrossRefGoogle Scholar
  102. 102.
    Harden, T. K., Wolfe. B. B., Sporn. J. R., Perkins, J. P., and Molinoff, P. B. 1977, Brain Res. 125: 99–108.PubMedCrossRefGoogle Scholar
  103. 103.
    Woodward. D. J., Hoffer, B. J., Siggins. G. R., and Bloom. F. E., 1971. Brain Res. 34: 7397.Google Scholar
  104. 104.
    Deskin, R., Seidler. F. J., Whitmore, W. L. and Slotkin. T. A., 1981, J. Neurochem. 36: 1683–1690.PubMedCrossRefGoogle Scholar
  105. 105.
    Cannon, W. B., Newton, H. F., Bright. E. M., Menkin, V., and Moore, R. M., 1929, Am. J. Physiol. 89: 84–107.Google Scholar
  106. 106.
    Cannon. W. B. Lewis, J. T., and Britton. S. W., 1926. Am. J. Physiol. 77: 326–352.Google Scholar
  107. 107.
    Cannon, W. B., and Rosenblueth, A., 1949, The Supersensitivitv of Denervated Structures, Macmillan, New York.Google Scholar
  108. 108.
    Heffner, T. G., Zigmond, M. J., and Stricker, E. M., 1977, J. Pharmacol. Exp. Ther. 201: 386–399.PubMedGoogle Scholar
  109. 109.
    Schoenfeld, R. I., and Zigmond, M. J., 1973, Frontiers in Catecholamine Research (E. Usdin and S. H. Snyder, eds.), Pergamon Press, Oxford. pp. 695–700.Google Scholar
  110. 110.
    Zigmond, M. J., and Stricker, E. M., 1973, Science 182: 717–720.PubMedCrossRefGoogle Scholar
  111. 111.
    Harvey, J. A., 1965, J. Pharmacol. Exp. Ther. 147: 244–251.PubMedGoogle Scholar
  112. 112.
    Marshall, J. F., Richardson, J. S., and Teitelbaum. P. 1974, J. Comp. Physiol. Psychol. 87: 808–830.PubMedCrossRefGoogle Scholar
  113. 113.
    Zigmond, M. J., and Stricker, E. M. 1972, Science 177: 1211–1214.PubMedCrossRefGoogle Scholar
  114. 114.
    Stricker, E. M., and Zigmond. M. J., 1985, Handbook of Physiology: Intrinsic Regulatory Systems of the Brain (F. E. Bloom, ed.), American Physiological Society, Washington, (in press).Google Scholar
  115. 115.
    Siggins, G. R., 1978, Psychopharmacology:.4 Generation of Progress 1M. A. Lipton, A. DiMascio, and K. F. Killan, eds.), Raven Press. New York, pp. 143–157.Google Scholar
  116. 116.
    Sethy, V. H., and VanWoert, M. H., 1974, Nature 251: 528–530.CrossRefGoogle Scholar
  117. 117.
    Trabucchi, M., Cheney, D. L., Racagni, G., and Costa, E., 1975, Brain Res. 85: 130–134.PubMedCrossRefGoogle Scholar
  118. 118.
    Orr, W. B., Berger, T. W., Stricker, E. M. and Zigmond, M. J., 1982, Soc. Neurosci. Abstr. 8: 483.Google Scholar
  119. 119.
    Schultz, W., and Ungerstedt, U., 1978, Exp. Brain Res. 33: 159–171.PubMedCrossRefGoogle Scholar
  120. 120.
    Agid, Y., Guyenet, P., Glowinski. J. Beaujouan, J. C., and Javoy, F., 1975, Brain Res. 86: 488–492.PubMedCrossRefGoogle Scholar
  121. 121.
    Rommelspacher, H., and Kuhar, M. J. 1975, Life Sci. 16: 65–70.PubMedCrossRefGoogle Scholar
  122. 122.
    Snyder, A. M., Zigmond, M. J., and Stricker, E. M. 1982, Soc. Neurosci. Abstr. 8: 362.Google Scholar
  123. 123.
    Stricker, E. M. Cooper. P. H., Marshall, J. F., and Zigmond. M. J., 1979. J. Comp. Physiol. Psychol. 93: 512–521.PubMedCrossRefGoogle Scholar
  124. 124.
    Stricker, E. M., and Zigmond, M.J., 1976, Progress in Psychobiology and Physiological Psychology (J. M. Sprague and A. N. Epstein, eds.), Academic Press, New York, pp. 121–189.Google Scholar
  125. 125.
    Algeri, S., Bonati, M., Brunello, N., and Ponzio. F. 1977, Brain Res. 132: 569–574.PubMedCrossRefGoogle Scholar
  126. 126.
    McGeer, E. G., Fibiger, H. C., McGeer, P. L., and Wickson. V., 1971. Exp. Gerontol. 6: 391–396.PubMedCrossRefGoogle Scholar
  127. 127.
    Govoni, S., Spano, P. F., and Trabucchi. M. 1978, J. Pharm. Pharmacol. 30: 448–449.PubMedCrossRefGoogle Scholar
  128. 128.
    Schmidt, M. J., and Thornberry. J. F., 1978, Brain Res. 139: 169–177.PubMedCrossRefGoogle Scholar
  129. 129.
    Severson, J. A., and Finch, C. E. 1980, Brain Res. 192: 147–162.PubMedCrossRefGoogle Scholar
  130. 130.
    Hirschhorn, I. D., Makman, M. H., and Sharpless. N. S., 1982, Brain Res. 234: 357–368.PubMedCrossRefGoogle Scholar
  131. 131.
    Randall, P. K., 1980, Peptides 1(Suppl. 11: 177–184.Google Scholar
  132. 132.
    Greenberg, L. H., and Weiss, B., 1978. Science 201: 61–63.PubMedCrossRefGoogle Scholar
  133. 133.
    Finch, C. E., Randall, P. K., and Marshall, J. F., 1981. Anna. Rev. Gerontol. Geriatr. 2: 4987.Google Scholar
  134. 134.
    Marshall, J. F. and Berrios, N., 1979, Science 206: 477–479.PubMedCrossRefGoogle Scholar
  135. 135.
    Masserano, J. M., and Weiner, N., 1979, Mol. Pharmacol. 16: 513–528.PubMedGoogle Scholar
  136. 136.
    Sherman, K. A., Zigmond, M. J., and Honin, 1. 1978, Life Sci. 23: 1863–1870.PubMedCrossRefGoogle Scholar
  137. 137.
    Tassin, J. P., Velley, L., Stinus, L., Blanc, G. Glowinski, J., and Thierry, A. M., 1975, Brain Research 83: 93–106.Google Scholar
  138. 138.
    Stachowiak, M., Bruno, J., Stricker, E., and Zigmond. M., 1984. Soc. Neurosci. Abstr. 10: 880.Google Scholar

Copyright information

© Springer Science+Business Media New York 1985

Authors and Affiliations

  • Michael J. Zigmond
    • 1
  • Edward M. Stricker
    • 2
  1. 1.Department of Biological SciencesUniversity of PittsburghPittsburghUSA
  2. 2.Department of PsychologyUniversity of PittsburghPittsburghUSA

Personalised recommendations